Testing a glucose monitor in critically ill surgery patients
Part of Hormones & metabolism clinical trials.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You are admitted to an intensive care unit (ICU)
- You need blood sugar monitoring and insulin therapy
- You are not taking high-dose vitamin C (ascorbic acid) or more than 4 grams of acetaminophen (Tylenol) per day
- You are physically and mentally able to wear a small glucose monitor continuously on your skin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to monitor blood sugar in the intensive care unit (ICU) using a small sensor that sends readings wirelessly to the care team. If you have high blood sugar and are on insulin, this could help keep your levels more stable without frequent finger pricks.
This study tests using a continuous glucose monitor (a small sensor that checks blood sugar all the time) to help guide the dose of insulin given through an IV. This is for patients who are not in the ICU but need insulin therapy for over a day, especially those on steroids or special nutrition.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This trial checks how well a continuous glucose monitor works during heart surgery. It aims to help manage blood sugar levels more safely in the operating room.
This trial tests a continuous glucose monitoring system for people in the intensive care unit (ICU). It checks how well the device measures blood sugar and if it can help predict outcomes for critically ill patients.
This study is testing a small wearable sensor (continuous glucose monitor) to track blood sugar levels during heart surgery that uses a heart-lung machine. The goal is to see if it works well in that setting, which could improve how doctors manage your sugar levels during surgery.
Hear when a new CGM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.